3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Esophageal Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Carboplatin
11
pembrolizumab
10
Paclitaxel
10
Fluorouracil
9
Oxaliplatin
8
Radiotherapy
7
Nivolumab
7
Leucovorin
6
Cisplatin
6
Radiotherapy, Intensity-Modulated
5
Magnetic Resonance Spectroscopy
5
Taxes
4
durvalumab
3
Trastuzumab
3
Surgical Procedures, Operative
3
Capecitabine
3
relatlimab
2
Standard of Care
2
Specimen Handling
2
Radiation
2
Proton Therapy
2
Practice Guidelines as Topic
2
Irinotecan
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Docetaxel
2
Cetuximab
2
Blood Specimen Collection
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Neoplasms
×
zanidatamab
×
Clear all
NCT05152147
2026-05-19
HERIZON-GEA-01
Jazz Pharmaceuticals
Phase 3
Active not recruiting
920 enrolled